Clinical trial Recruiting at 1 site Observational Ages 13 to 80

How quickly blood albumin returns after major liver, pancreas, or bile-duct surgery predicts recovery

Official title: Time to Post-operative Recovery of Serum Albumin as a Predictor of Outcome in Major Hepato Pancreato Biliary Surgeries

Run by Institute of Liver and Biliary Sciences, India · NCT07263061 · Data updated 2026-11-12

This study will see if the speed at which serum albumin returns after major hepato‑pancreato‑biliary surgery predicts complications and hospital stay for patients aged 12 and up.

More Bile Duct Cancer trials

Quick facts

Study typeObservational
Ages13 Years to 80 Years
SexAll
Enrollment1000 (estimated)
SponsorInstitute of Liver and Biliary Sciences, India
Academic / other
Locations1 site (New Delhi, National Capital Territory of Delhi)
StatusRecruiting
StartedDecember 7, 2025
Main results expectedOctober 23, 2026
Study endsOctober 23, 2026
Registry record updatedDecember 31, 2025
Trial IDNCT07263061 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged over 12 undergoing planned major hepato‑pancreato‑biliary (liver, pancreas, or bile duct) surgery at the enrolling center who can provide consent.

Probably not a fit

Patients with chronic liver disease, nephrotic syndrome, protein‑losing enteropathies, inflammatory bowel disease, those undergoing emergency surgery, or those unable/unwilling to consent are excluded and unlikely to benefit from the study findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational cohort that combines a retrospective arm (data from 2010 onward) with contemporaneous data collection at a single tertiary hepatobiliary center. Investigators will track perioperative serum albumin levels and record the time until albumin recovers toward baseline or a predefined threshold. They will compare that recovery time with post‑operative outcomes such as complications, morbidity, and length of hospital stay while accounting for factors like fluid management and albumin supplementation. The goal is to determine whether earlier albumin recovery is associated with lower complication rates and shorter admissions.

Why it matters

Potential benefit: If successful, the approach could help clinicians identify patients at higher risk of complications earlier and tailor monitoring or interventions to shorten recovery and hospital stay.

How similar studies have gone: Prior observational work has linked low perioperative albumin with worse outcomes, but contemporary data specifically using the time to albumin recovery as a prognostic marker are sparse and relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. All patients undergoing major Hepato pancreatico Biliary surgeries.
2. Patients who are more than 12 years of age
3. Retrospective arm - Data from 2010

Exclusion Criteria:

1. Patients who refuse or are unable to give consent.
2. Patients with Nephrotic syndrome, Protein losing enteropathies, Inflammatory bowel
3. Disease, Chronic Liver Disease.
4. Emergency Surgeries

Where it's running

  • Ilbs
    New Delhi, National Capital Territory of Delhi, India
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.